Urinalysis Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028.Segmented By Product (Consumables, Instruments), By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), By Application (Disease Screening, Pregnancy & Fertility), By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, Research Laboratories & Institutes), By Region and Competition
Urinalysis Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing chronic disease prevalence, such as diabetes, kidney disease, etc.
Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine. This test is utilized to detect and manage syndromes of diseases, such as kidney disease, urinary tract infections, and diabetes. Further, urinalysis being informative and a non-invasive diagnostic method for the identification of kidney disease propels the market demand for urinalysis and adds to the market growth.
Moreover, rising awareness of kidney and urinary tract infections among the population and increasing government initiatives, along with growing healthcare investments for the identification and management of the growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.
Rising Prevalence of Chronic Diseases
Rising chronic disease prevalence such as diabetes is increasing worldwide, causing a huge health concern among the population around the world; for instance, according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. And above were affected with diabetes. Also, around one-third of the population was suffering some kind of kidney complication due to constant elevated blood pressure and blood sugar. The sedentary lifestyle, including consumption of unhealthy foods, alcohol consumption, increased processed food intake, lack of exercise, etc., is leading to the rising prevalence of diabetes around the world. To identify the glucose level in diabetic people or to confirm the diabetes occurrence in an individual, urinalysis is an important step and is frequently performed across the globe.
Growing Burden of Urinary Tract Infections (UTIs)
Urinalysis is a commonly utilized diagnostic procedure in the identification of a Urinary Tract infection (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, viruses, proteins, creatinine, and substances present in abnormal concentration. The most common cause of UTIs is when bacteria enter the urinary tract via the urethra and start flourishing in the bladder. The most common type of urine infection is bladder infection (cystitis). It can be used for the diagnosis of kidney infection (polynephritis). The rising risk of commonly observed UTI can be due to a previous UTI, pregnancy, age (older adults have increased UTI prevalence), menopause, poor hygiene, etc., and this is, in turn, supporting the market growth anticipated to boost in the forecast period.
The popularity of at-home Urine Testing Kits
At-home urine test kits are available for testing the presence of urinary tract infections at home. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in a few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at-home screening for urine drug tests with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is available for home-based tests suitable for home drug testing, workplace testing, school, college, and university drug testing, law enforcement testing, substantial drug abuse testing, etc.
Recent Development
In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offers dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.
Market Segmentation
Global Urinalysis Market is segmented based on the product, test type, application, end-user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc, etc.., are some of the major players operating in the global Urinalysis Market.
Report Scope:
In this report, Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
? Canada
? Mexico
? France
? United Kingdom
? Italy
? Spain
? Japan
? India
? South Korea
? Australia
? Saudi Arabia
? UAE
? Kuwait
? Argentina
? Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Urinalysis Market.
Available Customizations:
With the given Marketdata, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine. This test is utilized to detect and manage syndromes of diseases, such as kidney disease, urinary tract infections, and diabetes. Further, urinalysis being informative and a non-invasive diagnostic method for the identification of kidney disease propels the market demand for urinalysis and adds to the market growth.
Moreover, rising awareness of kidney and urinary tract infections among the population and increasing government initiatives, along with growing healthcare investments for the identification and management of the growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.
Rising Prevalence of Chronic Diseases
Rising chronic disease prevalence such as diabetes is increasing worldwide, causing a huge health concern among the population around the world; for instance, according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. And above were affected with diabetes. Also, around one-third of the population was suffering some kind of kidney complication due to constant elevated blood pressure and blood sugar. The sedentary lifestyle, including consumption of unhealthy foods, alcohol consumption, increased processed food intake, lack of exercise, etc., is leading to the rising prevalence of diabetes around the world. To identify the glucose level in diabetic people or to confirm the diabetes occurrence in an individual, urinalysis is an important step and is frequently performed across the globe.
Growing Burden of Urinary Tract Infections (UTIs)
Urinalysis is a commonly utilized diagnostic procedure in the identification of a Urinary Tract infection (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, viruses, proteins, creatinine, and substances present in abnormal concentration. The most common cause of UTIs is when bacteria enter the urinary tract via the urethra and start flourishing in the bladder. The most common type of urine infection is bladder infection (cystitis). It can be used for the diagnosis of kidney infection (polynephritis). The rising risk of commonly observed UTI can be due to a previous UTI, pregnancy, age (older adults have increased UTI prevalence), menopause, poor hygiene, etc., and this is, in turn, supporting the market growth anticipated to boost in the forecast period.
The popularity of at-home Urine Testing Kits
At-home urine test kits are available for testing the presence of urinary tract infections at home. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in a few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at-home screening for urine drug tests with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is available for home-based tests suitable for home drug testing, workplace testing, school, college, and university drug testing, law enforcement testing, substantial drug abuse testing, etc.
Recent Development
In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offers dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.
Market Segmentation
Global Urinalysis Market is segmented based on the product, test type, application, end-user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc, etc.., are some of the major players operating in the global Urinalysis Market.
Report Scope:
In this report, Global Urinalysis Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Urinalysis Market, By Product:
- Consumables
- Instruments
- Urinalysis Market, By Test Type:
- Pregnancy & Fertility Tests
- Biochemical Urinalysis
- Sediment Urinalysis
- Urinalysis Market, By Application:
- Disease Screening
- Pregnancy & Fertility
- Urinalysis Market, By End User:
- Diagnostic Laboratories
- Hospitals & Clinics
- Home Care Settings
- Research Laboratories & Institutes
- Urinalysis Market, By Region:
- North America
? Canada
? Mexico
- Europe
? France
? United Kingdom
? Italy
? Spain
- Asia-Pacific
? Japan
? India
? South Korea
? Australia
- Middle East & Africa
? Saudi Arabia
? UAE
? Kuwait
- South America
? Argentina
? Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Urinalysis Market.
Available Customizations:
With the given Marketdata, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional Market players (up to five).
1.PRODUCT OVERVIEW
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered.
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.RESEARCH METHODOLOGY
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation & Validation
2.7.Assumptions and Limitations
3.EXECUTIVE SUMMARY
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.VOICE OF CUSTOMER
5.GLOBAL URINALYSIS MARKET OUTLOOK.
5.1.Market Size & Forecast
5.1.1.By Value
5.2.Market Share & Forecast
5.2.1.By Product (Consumables & Instruments)
5.2.2.By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
5.2.3.By Application (Disease Screening and Pregnancy & Fertility)
5.2.4.By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
5.2.5.By Company (2022)
5.2.6.By Region
5.3.Product Market Map
6.ASIA-PACIFIC URINALYSIS MARKET OUTLOOK
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.Product
6.2.2.Test Type
6.2.3.Application
6.2.4.End user
6.2.5.By Country
6.3.Asia-Pacific: Country Analysis
6.3.1.China Urinalysis Market Outlook.
6.3.1.1.Market Size & Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share & Forecast
6.3.1.2.1.Product
6.3.1.2.2.Test Type
6.3.1.2.3.Application
6.3.1.2.4.End user
6.3.2.India Urinalysis Market Outlook.
6.3.2.1.Market Size & Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share & Forecast
6.3.2.2.1.Product
6.3.2.2.2.Test Type
6.3.2.2.3.Application
6.3.2.2.4.End user
6.3.3.South Korea Urinalysis Market Outlook
6.3.3.1.Market Size & Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share & Forecast
6.3.3.2.1.Product
6.3.3.2.2.Test Type
6.3.3.2.3.Application
6.3.3.2.4.End user
6.3.4.Japan Urinalysis Market Outlook
6.3.4.1.Market Size & Forecast
6.3.4.1.1.By Value
6.3.4.2.Market Share & Forecast
6.3.4.2.1.Product
6.3.4.2.2.Test Type
6.3.4.2.3.Application
6.3.4.2.4.End user
6.3.5.Australia Urinalysis Market Outlook
6.3.5.1.Market Size & Forecast
6.3.5.1.1.By Value
6.3.5.2.Market Share & Forecast
6.3.5.2.1.Product
6.3.5.2.2.Test Type
6.3.5.2.3.Application
6.3.5.2.4.End user
7.EUROPE URINALYSIS MARKET OUTLOOK
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.Product
7.2.2.Test Type
7.2.3.Application
7.2.4.End user
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.France Urinalysis Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.Product
7.3.1.2.2.Test Type
7.3.1.2.3.Application
7.3.1.2.4.End user
7.3.2.Germany Urinalysis Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.Product
7.3.2.2.2.Test Type
7.3.2.2.3.Application
7.3.2.2.4.End user
7.3.3.United Kingdom Urinalysis Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.Product
7.3.3.2.2.Test Type
7.3.3.2.3.Application
7.3.3.2.4.End user
7.3.4.Italy Urinalysis Market Outlook
7.3.4.1.Market Size & Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share & Forecast
7.3.4.2.1.Product
7.3.4.2.2.Test Type
7.3.4.2.3.Application
7.3.4.2.4.End user
7.3.5.Spain Urinalysis Market Outlook
7.3.5.1.Market Size & Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share & Forecast
7.3.5.2.1.Product
7.3.5.2.2.Test Type
7.3.5.2.3.Application
7.3.5.2.4.End user
8.NORTH AMERICA URINALYSIS MARKET OUTLOOK.
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.Product
8.2.2.Test Type
8.2.3.Application
8.2.4.End user
8.2.5.By Country
8.3.North America: Country Analysis
8.3.1.United States Urinalysis Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.Product
8.3.1.2.2.Test Type
8.3.1.2.3.Application
8.3.1.2.4.End user
8.3.2.Mexico Urinalysis Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.Product
8.3.2.2.2.Test Type
8.3.2.2.3.Application
8.3.2.2.4.End user
8.3.3.Canada Urinalysis Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.Product
8.3.3.2.2.Test Type
8.3.3.2.3.Application
8.3.3.2.4.End user
9.SOUTH AMERICA URINALYSIS MARKET OUTLOOK
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.Type
9.2.2.Product Type
9.2.3.Tissue
9.2.4.End user
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Urinalysis Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.Product
9.3.1.2.2.Test Type
9.3.1.2.3.Application
9.3.1.2.4.End user
9.3.2.Argentina Urinalysis Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.Product
9.3.2.2.2.Test Type
9.3.2.2.3.Application
9.3.2.2.4.End user
9.3.3.Colombia Urinalysis Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.Product
9.3.3.2.2.Test Type
9.3.3.2.3.Application
9.3.3.2.4.End user
10.MIDDLE EAST AND AFRICA URINALYSIS MARKET OUTLOOK
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.Product
10.2.2.Test Type
10.2.3.Application
10.2.4.End user
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Urinalysis Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.Product
10.3.1.2.2.Test Type
10.3.1.2.3.Application
10.3.1.2.4.End user
10.3.2.Saudi Arabia Urinalysis Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.Product
10.3.2.2.2.Test Type
10.3.2.2.3.Application
10.3.2.2.4.End user
10.3.3.UAE Urinalysis Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.Product
10.3.3.2.2.Test Type
10.3.3.2.3.Application
10.3.3.2.4.End user
10.3.4.Kuwait Urinalysis Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.Product
10.3.4.2.2.Test Type
10.3.4.2.3.Application
10.3.4.2.4.End user
11.MARKET DYNAMICS
11.1.Drivers
11.2.Challenges
12.MARKET TRENDS & DEVELOPMENTS
12.1.Recent Developments
12.2.Mergers & Acquisitions
12.3.Product Developments
13.COMPETITIVE LANDSCAPE
13.1.Business Overview
13.2.Company Snapshot
13.3.Products & Services
13.4.Financials (In case of listed companies)
13.5.Recent Developments
13.6.SWOT Analysis
13.6.1.F. Hoffmann-La Roche Ltd.
13.6.2.Siemens Healthineers AG.
13.6.3.Abbott Laboratories
13.6.4.Cardinal Health Inc.
13.6.5.Danaher Corporation
13.6.6.Sysmex Corporation
13.6.7.Quidel Corporation
13.6.8.Becton, Dickinson & Company
13.6.9.Bio-Rad Laboratories Inc.
13.6.10.EKF Diagnostic s Holdings plc
14.STRATEGIC RECOMMENDATIONS
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered.
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.RESEARCH METHODOLOGY
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation & Validation
2.7.Assumptions and Limitations
3.EXECUTIVE SUMMARY
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.VOICE OF CUSTOMER
5.GLOBAL URINALYSIS MARKET OUTLOOK.
5.1.Market Size & Forecast
5.1.1.By Value
5.2.Market Share & Forecast
5.2.1.By Product (Consumables & Instruments)
5.2.2.By Test Type (Pregnancy & Fertility Tests, Biochemical Urinalysis, and Sediment Urinalysis)
5.2.3.By Application (Disease Screening and Pregnancy & Fertility)
5.2.4.By End user (Diagnostic Laboratories, Hospitals & Clinics, Home Care Settings, and Research Laboratories & Institutes)
5.2.5.By Company (2022)
5.2.6.By Region
5.3.Product Market Map
6.ASIA-PACIFIC URINALYSIS MARKET OUTLOOK
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.Product
6.2.2.Test Type
6.2.3.Application
6.2.4.End user
6.2.5.By Country
6.3.Asia-Pacific: Country Analysis
6.3.1.China Urinalysis Market Outlook.
6.3.1.1.Market Size & Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share & Forecast
6.3.1.2.1.Product
6.3.1.2.2.Test Type
6.3.1.2.3.Application
6.3.1.2.4.End user
6.3.2.India Urinalysis Market Outlook.
6.3.2.1.Market Size & Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share & Forecast
6.3.2.2.1.Product
6.3.2.2.2.Test Type
6.3.2.2.3.Application
6.3.2.2.4.End user
6.3.3.South Korea Urinalysis Market Outlook
6.3.3.1.Market Size & Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share & Forecast
6.3.3.2.1.Product
6.3.3.2.2.Test Type
6.3.3.2.3.Application
6.3.3.2.4.End user
6.3.4.Japan Urinalysis Market Outlook
6.3.4.1.Market Size & Forecast
6.3.4.1.1.By Value
6.3.4.2.Market Share & Forecast
6.3.4.2.1.Product
6.3.4.2.2.Test Type
6.3.4.2.3.Application
6.3.4.2.4.End user
6.3.5.Australia Urinalysis Market Outlook
6.3.5.1.Market Size & Forecast
6.3.5.1.1.By Value
6.3.5.2.Market Share & Forecast
6.3.5.2.1.Product
6.3.5.2.2.Test Type
6.3.5.2.3.Application
6.3.5.2.4.End user
7.EUROPE URINALYSIS MARKET OUTLOOK
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.Product
7.2.2.Test Type
7.2.3.Application
7.2.4.End user
7.2.5.By Country
7.3.Europe: Country Analysis
7.3.1.France Urinalysis Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.Product
7.3.1.2.2.Test Type
7.3.1.2.3.Application
7.3.1.2.4.End user
7.3.2.Germany Urinalysis Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.Product
7.3.2.2.2.Test Type
7.3.2.2.3.Application
7.3.2.2.4.End user
7.3.3.United Kingdom Urinalysis Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.Product
7.3.3.2.2.Test Type
7.3.3.2.3.Application
7.3.3.2.4.End user
7.3.4.Italy Urinalysis Market Outlook
7.3.4.1.Market Size & Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share & Forecast
7.3.4.2.1.Product
7.3.4.2.2.Test Type
7.3.4.2.3.Application
7.3.4.2.4.End user
7.3.5.Spain Urinalysis Market Outlook
7.3.5.1.Market Size & Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share & Forecast
7.3.5.2.1.Product
7.3.5.2.2.Test Type
7.3.5.2.3.Application
7.3.5.2.4.End user
8.NORTH AMERICA URINALYSIS MARKET OUTLOOK.
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.Product
8.2.2.Test Type
8.2.3.Application
8.2.4.End user
8.2.5.By Country
8.3.North America: Country Analysis
8.3.1.United States Urinalysis Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.Product
8.3.1.2.2.Test Type
8.3.1.2.3.Application
8.3.1.2.4.End user
8.3.2.Mexico Urinalysis Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.Product
8.3.2.2.2.Test Type
8.3.2.2.3.Application
8.3.2.2.4.End user
8.3.3.Canada Urinalysis Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.Product
8.3.3.2.2.Test Type
8.3.3.2.3.Application
8.3.3.2.4.End user
9.SOUTH AMERICA URINALYSIS MARKET OUTLOOK
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.Type
9.2.2.Product Type
9.2.3.Tissue
9.2.4.End user
9.2.5.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Urinalysis Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.Product
9.3.1.2.2.Test Type
9.3.1.2.3.Application
9.3.1.2.4.End user
9.3.2.Argentina Urinalysis Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.Product
9.3.2.2.2.Test Type
9.3.2.2.3.Application
9.3.2.2.4.End user
9.3.3.Colombia Urinalysis Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.Product
9.3.3.2.2.Test Type
9.3.3.2.3.Application
9.3.3.2.4.End user
10.MIDDLE EAST AND AFRICA URINALYSIS MARKET OUTLOOK
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.Product
10.2.2.Test Type
10.2.3.Application
10.2.4.End user
10.2.5.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Urinalysis Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.Product
10.3.1.2.2.Test Type
10.3.1.2.3.Application
10.3.1.2.4.End user
10.3.2.Saudi Arabia Urinalysis Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.Product
10.3.2.2.2.Test Type
10.3.2.2.3.Application
10.3.2.2.4.End user
10.3.3.UAE Urinalysis Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.Product
10.3.3.2.2.Test Type
10.3.3.2.3.Application
10.3.3.2.4.End user
10.3.4.Kuwait Urinalysis Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.Product
10.3.4.2.2.Test Type
10.3.4.2.3.Application
10.3.4.2.4.End user
11.MARKET DYNAMICS
11.1.Drivers
11.2.Challenges
12.MARKET TRENDS & DEVELOPMENTS
12.1.Recent Developments
12.2.Mergers & Acquisitions
12.3.Product Developments
13.COMPETITIVE LANDSCAPE
13.1.Business Overview
13.2.Company Snapshot
13.3.Products & Services
13.4.Financials (In case of listed companies)
13.5.Recent Developments
13.6.SWOT Analysis
13.6.1.F. Hoffmann-La Roche Ltd.
13.6.2.Siemens Healthineers AG.
13.6.3.Abbott Laboratories
13.6.4.Cardinal Health Inc.
13.6.5.Danaher Corporation
13.6.6.Sysmex Corporation
13.6.7.Quidel Corporation
13.6.8.Becton, Dickinson & Company
13.6.9.Bio-Rad Laboratories Inc.
13.6.10.EKF Diagnostic s Holdings plc
14.STRATEGIC RECOMMENDATIONS
